Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Gene. 2020 Aug 30;753:144816. doi: 10.1016/j.gene.2020.144816. Epub 2020 May 27.
Hemizygosity of the MIR17HG gene encoding the miR-17 ~ 92 cluster is associated with Feingold syndrome 2 characterized by intellectual disability, skeletal abnormalities, short stature, and microcephaly. Here, we report on a female with a de novo 13q31.3 microduplication encompassing MIR17HG but excluding GPC5. She presented developmental delay, skeletal and digital abnormalities, and features such as tall stature and macrocephaly mirroring those of Feingold syndrome 2 patients. The limited extent of the proband's rearrangement to the miR cluster and the corresponding normal expression level of the neighboring GPC5 in her cells, together with previously described data on affected individuals of two families carrying overlapping duplications of the miR-17 ~ 92 cluster that comprise part of GPC5, who likewise presented macrocephaly, developmental delay, as well as skeletal, digital and stature abnormalities, allow to define a new syndrome due to independent microduplication of the miR-17 ~ 92 cluster.
MIR17HG 基因编码 miR-1792 簇的杂合性缺失与 Feingold 综合征 2 有关,其特征为智力残疾、骨骼异常、身材矮小和小头畸形。在这里,我们报告了一名女性患有 13q31.3 微重复,包含 MIR17HG 但不包括 GPC5。她表现出发育迟缓、骨骼和数字异常,以及高身材和大头畸形等特征,与 Feingold 综合征 2 患者相似。先证者的重排范围仅限于 miR 簇,以及其细胞中邻近的 GPC5 的表达水平正常,再加上之前描述的两个携带 miR-1792 簇重叠重复的家族受影响个体的数据,该重复包含部分 GPC5,他们同样表现为大头畸形、发育迟缓,以及骨骼、数字和身高异常,因此可以定义一种新的综合征,这是由于 miR-17~92 簇的独立微重复所致。